In this review, we will discuss the current status of several anti–PD-1 and anti–PD-L1 antibodies in clinical development and their direction for the future.
Joseph Paul Eder, MD
Advertisement
Articles by Joseph Paul Eder, MD
Advertisement
Latest Updated Articles
- Prospects for Targeting PD-1 and PD-L1 in Various Tumor Types
Published: November 11th 2014 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How to Address Racial and Social Disparities in Pancreatic Cancer Care?
2
Handling the Burden of Financial Toxicity While Undergoing Cancer Therapy
3
As Late-Career Oncologists Retire, Who Will Fill the Geographic Gaps?
4
PEG Hydrogel Reduces Rectal Radiation During Cervical Cancer Therapy
5
